Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical model

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 161-168

  Stilianakis, Nikolaos I ^a   Boucher, Charles A B ^b   De Jong, Menno D ^c   Van Leeuwen, Remko ^c   Schuurman, Rob ^b   De Boer, Rob J ^b  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ARTICLE; DRUG RESISTANCE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL MODEL; MUTATION RATE; PRIORITY JOURNAL; VIRUS MUTANT;

EID: 0031060375     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.161-168.1997     Document Type: Article

References (37)

1. Back, N. K. T., M. Nijhuis, W. Keulen, C. A. B. Boucher, B. B. Oude Essink, A. B. P. Van Kuilenburg, A. H. Van Gennips, and B. Berkhout. 1996. Reduced replication of 3TC-resistant HIV-1 variants in primary- cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J. 15:4040-4049.
2. Bofill, M., A. Mocroft, M. Lipman, E. Medina, N. J. Borthwick, C. A. Sabin, A. Timms, M. Winter, E. Baptista, M. A. Johnson, C. A. Lee, A. N. Phillips, and G. Janossy. 1996. Increased numbers of primed CD8+ , CD38+, CD5RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS 10:827-834.
3. Boucher, C. A. B., M. Tersmette, J. M. A. Lange, P. Kellam, R. E. Y. De Goede, B. J. W. Mulder, G. Darby, J. Goudsmit, and B. A. Larder. 1990. Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy. Lancet 336:585-590.
4. Boucher, C. A. B., E. O'Sallivan, B. J. W. Mulder, C. Ramautarsing, P. Kellam, G. Darby, J. M. A. Lange, J. Goudsmit, and B. A. Larder. 1992. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. J. Infect. Dis. 165:105-110.
5. Coffin, J. M. 1995. HIV-1 population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
6. De Boer, R. J., and C. A. B. Boucher. 1996. Anti-CD4 therapy for AIDS suggested by mathematical models. Proc. R. Soc. Lend. B 263:899-905.
7. De Boer, R. J., and A. S. Perelson. Target cell limited and immune control models of HIV infection: a comparison. Submitted for publication.
8. De Jong, M. D., J. Veenstra, N. I. Stilianakis, R. Schuurman, J. M. A. Lange, R. J. De Boer, and C. A. B. Boucher. 1996. Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of HIV-1 RNA load suppression by zidovudine. Proc. Natl. Acad. Sci. USA 93:5501-5506.
9. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV-1 during the incubation period of AIDS. Nature 362:359-362.
10. + cells per cubic millimeter. N. Engl. J. Med. 333:1662-1669.
11. + T-cell subpopulations. J. Theor. Biol. 170:367-391.
12. Fauci, A. S. 1993. Multifactorial nature of human immunodeficiency virus diseases: implications for therapy. Science 262:1011-1018.
13. Feinberg, M. B. 1996. Changing the natural history of HIV disease. Lancet 348:239-246.
14. Frost, S. D. W., and A. R. McLean. 1994. Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV-1 infection. AIDS 8:323-332.
15. Goudsmit, J., A. De Ronde, D. D. Ho, and A. S. Perelson. 1996. HIV-1 fitness in vivo: Calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase. J. Virol. 70:5662-5664.
16. Goudsmit, J., A. De Ronde, E. R. De Rooij, and R. J. De Boer. Broad spectrum of in vivo fitness of HIV-1 subpopulations differing at reverse transcriptase codons 41 and 215. Submitted for publication.
17. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
18. Holford, N. H., and L. B. Sheiner. 1982. Kinetics of pharmacologic response. Pharmacol. Ther. 16:143-166.
19. Kellam, P., C. A. B. Boucher, and B. A. Larder. 1992. Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine. Proc. Natl. Acad. Sci. USA 89:1934-1938.
20. Keulen, W., C. A. B. Boucher, and B. Berkhout. 1996. Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins. Antiviral Res. 31:45-57.
21. Larder, B. A., G. Darby, and D. D. Richman. 1989. HIV-1 with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243:1731-1734.
22. Larder, B. A., and S. D. Kemp. 1989. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246: 1155-1158.
23. Larder, B. A., P. Kellam, and S. D. Kemp. 1991. Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes. AIDS 5:137-144.
24. Loveday, C., S. Kaye, M. Tenant-Flowers, M. Semple, U. Ayliffe, I. V. D. Weller, and R. S. Tedder. 1995. HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy. Lancet 345:820-824.
25. Mackall, C. L., C. V. Bare, L. A. Granger, S. O. Sharrow, J. A. Titus, and R. E. Gress. 1996. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J. Immunol. 156:4609-4616.
26. Malone, J. L., T. E. Simms, G. C. Gray, K. F. Wagner, J. R. Burger, and D. S. Burke. 1990. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1 infected patients: total lymphocyte counts fluctuation and diurnal cycle are important. J. Acquired Immune Defic. Syndr. 3:144-151.
27. Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087-5094.
28. McLean, A. R., and M. A. Nowak. 1992. Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV. AIDS 6:71-79.
29. McLean, A. R., and C. A. Michie. 1995. In vivo estimates of division and death rates of human lymphocytes. Proc. Natl. Acad. Sci. USA 92:3707-3711.
30. Najera, I., A. Hoguin, M. E. Quinones-Mateu, M. A. Munoz-Fernandez, R. Najera, C. Lopez-Galindez, and E. Domingo. 1995. pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 69:23-31.
31. 30a.Nijhuis, M., et al. Unpublished data.
32. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox., J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV-1 infection is active in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358.
33. + T cells. Math. Biosci. 114:81-125.
34. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell lifespan and viral generation time. Science 271:1582-1586.
35. Richman, D. D., J. M. Grimes, and S. W. Lagakos. 1990. Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus. J. Acquired Immune Defic. Syndr. 3:743-746.
36. Schuurman, R., M. Nijhuis, R. Van Leeuwen, P. Schipper, D. De Jong, P. Collis, S. A. Danner, J. Mulder, C. Loveday, C. Christopherson, S. Kwok, J. Sninsky, and C. A. B. Boucher. 1995. Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine. J. Infect. Dis. 171:1411-1419.
37. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.